Matthew Korenberg
2019
Compensation breakdown
| Non-Equity Incentive Plan | $186,667 |
|---|---|
| Option Awards | $1,445,555 |
| Salary | $466,667 |
| Stock Awards | $1,466,580 |
| Other | $5,734 |
| Total | $3,571,203 |
Korenberg received $1.5M in stock awards, accounting for 41% of the total pay in 2019.
Korenberg also received $186.7K in non-equity incentive plan, $1.4M in option awards, $466.7K in salary and $5.7K in other compensation.
Rankings
In 2019, Matthew Korenberg's compensation ranked 3,394th out of 13,971 executives tracked by ExecPay. In other words, Korenberg earned more than 75.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,394 out of 13,971 | 76th |
Division Manufacturing | 1,232 out of 5,695 | 78th |
Major group Chemicals And Allied Products | 420 out of 2,194 | 81st |
Industry group Drugs | 348 out of 1,880 | 82nd |
Industry Pharmaceutical Preparations | 261 out of 1,392 | 81st |
Pay ratio
| Matthew Korenberg's Pay | $3,571,203 |
|---|---|
| Median Employee's Pay | $109,795 |
| Pay Ratio | 33to 1 |
In 2019, the annual total compensation of Matthew Korenberg was $3,571,203.
The annual total compensation of the median employee at Ligand Pharmaceuticals was $109,795.
The ratio of Matthew Korenberg's pay to the pay of median employee was therefore 33 to one.
Korenberg's colleagues
We found three more compensation records of executives who worked with Matthew Korenberg at Ligand Pharmaceuticals in 2019.